• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Silo Pharma, Inc. - Common Stock (NQ:SILO)

0.3926 +0.0036 (+0.93%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Silo Pharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Silo Pharma Executes Letter of Intent with Allucent to Support Phase 1 Clinical Development of SPC-15
December 30, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
November 17, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Selects Alphaledger’s T12 Fund for Tokenized Real-World Asset Investments on Solana Blockchain
October 29, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Issues Update on Milestone Achievements in PTSD Drug Development and New Digital Assets Treasury Program
October 23, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Expands Crypto Treasury with First Strategic Bitcoin Purchase Reinforcing Company’s Commitment to Multi-Chain Growth
October 08, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Acquires ResearchCoin (RSC) Crypto Tokens in Support of Decentralized Science (DeSci)
October 06, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Announces Closing of $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
October 01, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Announces $2.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
September 30, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Updates Strategic Agreement with Fireblocks to Secure Crypto Treasury Management
September 29, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Signs Strategic Agreement with Fireblocks to Advance Crypto Treasury Strategy Acquisition and Security
September 23, 2025
Highly secure, institutional-grade infrastructure supports Bitcoin, Ethereum and Solana treasury strategy 
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Announces Initial Investment in Ethereum and Solana under Cryptocurrency Treasury Strategy
September 16, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Adds Japanese Patent to Expanding Global IP Portfolio for Licensed PTSD Drug
September 09, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Secures Australian Patent Covering Licensed PTSD Drug Candidate Expanding Global IP Portfolio
September 03, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma’s Alzheimer’s Candidate SPC-14 Featured in Leading Scientific Peer-reviewed Journal
August 21, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma’s PTSD Candidate SPC-15 Achieves Positive Safety Milestone, Paving Way for Accelerated Clinical Trials Under 505(b)(2) Pathway
August 19, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform
August 05, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Announces Completion of Dosing in Safety Study of PTSD Drug SPC-15
July 16, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Expects SPC-15 PTSD Study Results Within 90 Days
July 07, 2025
Via Investor Brand Network
News headline image
Silo Pharma Advances PTSD Drug SPC-15 Toward Planned 2025 IND Submission with Pre-Clinical Study Data Expected in Q3 2025
July 07, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
June 25, 2025
Via Get News
Topics Intellectual Property
News headline image
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
June 25, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Enters into Letter of Intent to Form Joint Venture with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
June 25, 2025
Via Press Release Distribution Service
Topics Intellectual Property
PsychedelicNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Receives USPTO Notice of Allowance for PTSD Treatment Patent
June 11, 2025
Via Investor Brand Network
Topics Intellectual Property
News headline image
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
June 11, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
News headline image
Silo Pharma Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset
June 05, 2025
Strategic decision positions Company to diversify treasury holdings with a long-term digital store of value 
From Silo Pharma, Inc.
Via GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Advances PTSD Treatment with Nasal Spray Device Study for SPC-15
May 21, 2025
Via Investor Brand Network
News headline image
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15
May 21, 2025
Study is expected to deliver final device data and documentation needed for planned FDA IND submission 
From Silo Pharma, Inc.
Via GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Closes $2 Million Public Offering of Shares and Warrants
May 19, 2025
Via Investor Brand Network
News headline image
Silo Pharma Announces Closing of $2 Million Public Offering
May 16, 2025
From Silo Pharma, Inc.
Via GlobeNewswire
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Prices $2 Million Public Offering of Common Stock and Warrants
May 16, 2025
Via Investor Brand Network
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap